Neurocritical Care

, Volume 17, Issue 1, pp 139–145 | Cite as

A New Technology for Detecting Cerebral Blood Flow: A Comparative Study of Ultrasound Tagged NIRS and 133Xe-SPECT

  • Henrik W. Schytz
  • Song Guo
  • Lars T. Jensen
  • Moshe Kamar
  • Asaph Nini
  • Daryl R. Gress
  • Messoud AshinaEmail author
Take Notice Technology


There is a need for real-time non-invasive, continuous monitoring of cerebral blood flow (CBF) during surgery, in intensive care units and clinical research. We investigated a new non-invasive hybrid technology employing ultrasound tagged near infrared spectroscopy (UT-NIRS) that may estimate changes in CBF using a cerebral blood flow index (CFI). Changes over time for UT-NIRS CFI and 133Xenon single photon emission computer tomography (133Xe-SPECT) CBF data were assessed in 10 healthy volunteers after an intravenous bolus of acetazolamide. UT-NIRS CFI was measured continuously and SPECT CBF was measured at baseline, 15 and 60 min after acetazolamide. We found significant changes over time in CFI by UT-NIRS and CBF by SPECT after acetazolamide (P ≤ 0.001). Post hoc tests showed a significant increase in CFI (P = 0.011) and SPECT CBF (P < 0.001) at 15 min after acetazolamide injection. There was a significant correlation between CFI and SPECT CBF values (r = 0.67 and P ≤ 0.033) at 15 min, but not at 60 min (P ≥ 0.777). UT-NIRS detected an increase in CFI following an acetazolamide bolus, which correlated with CBF measured with 133Xe-SPECT. This study demonstrates that UT-NIRS technology may be a promising new technique for non-invasive and real-time bedside CBF monitoring.


Cerebral blood flow Ultrasound tagged near infrared spectroscopy 133Xenon single photon emission computer tomography Acetazolamide Monitoring 



The authors wish to thank lab technicians Annette Foldager for her dedicated and excellent assistance and to Zmira Silman for advise on the statistical analysis. The study was supported by the Lundbeck Foundation via the Lundbeck Foundation Center for Neurovascular Signaling (LUCENS) and the Augustinus Foundation, Denmark. The study was funded by Ornim Medical Ltd. (Lod, Israel).

Conflict of interest

Dr. Schytz, Dr. Guo, Dr. Jensen and Dr. Ashina report no disclosures in any relation to this study. Dr. Kamar is vice president of medical affairs at Ornim Medical. Dr. Gress is a member of Ornim Medical Inc.’s scientific advisory board and holds stock options of the company. Dr. Nini is a medical advisor of Ornim.


  1. 1.
    Panerai RB. Complexity of the human cerebral circulation. Philos Trans A Math Phys Eng Sci. 2009;367:1319–36.CrossRefGoogle Scholar
  2. 2.
    Dagal A, Lam AM. Cerebral blood flow and the injured brain: how should we monitor and manipulate it? Curr Opin Anaesthesiol. 2011;24:131–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Griffiths PD, Hoggard N, Dannels WR, Wilkinson ID. In vivo measurement of cerebral blood flow: a review of methods and applications. Vasc Med. 2001;6:51–60.PubMedGoogle Scholar
  4. 4.
    Boas DA, Dale AM, Franceschini MA. Diffuse optical imaging of brain activation: approaches to optimizing image sensitivity, resolution, and accuracy. Neuroimage. 2004;23(Suppl 1):S275–88.PubMedCrossRefGoogle Scholar
  5. 5.
    Damian MS, Schlosser R. Bilateral near infrared spectroscopy in space-occupying middle cerebral artery stroke. Neurocrit Care. 2007;6:165–73.PubMedCrossRefGoogle Scholar
  6. 6.
    Hoshi Y. Functional near-infrared optical imaging: utility and limitations in human brain mapping. Psychophysiology. 2003;40:511–20.PubMedCrossRefGoogle Scholar
  7. 7.
    Strangman G, Boas DA, Sutton JP. Non-invasive neuroimaging using near-infrared light. Biol Psychiatr. 2002;52:679–93.CrossRefGoogle Scholar
  8. 8.
    Highton D, Elwell C, Smith M. Noninvasive cerebral oximetry: is there light at the end of the tunnel? Curr Opin Anaesthesiol. 2010;23:576–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Holzschuh M, Woertgen C, Metz C, Brawanski A. Comparison of changes in cerebral blood flow and cerebral oxygen saturation measured by near infrared spectroscopy (NIRS) after acetazolamide. Acta Neurochir (Wien). 1997;139:58–62.CrossRefGoogle Scholar
  10. 10.
    Kaminogo M, Ichikura A, Shibata S, Toba T, Yonekura M. Effect of acetazolamide on regional cerebral oxygen saturation and regional cerebral blood flow. Stroke. 1995;26:2358–60.PubMedCrossRefGoogle Scholar
  11. 11.
    Tachtsidis I, Tisdall M, Delpy DT, Smith M, Elwell CE. Measurement of cerebral tissue oxygenation in young healthy volunteers during acetazolamide provocation: a transcranial Doppler and near-infrared spectroscopy investigation. Adv Exp Med Biol. 2008;614:389–96.PubMedCrossRefGoogle Scholar
  12. 12.
    Schytz HW, Wienecke T, Jensen LT, Selb J, Boas DA, Ashina M. Changes in cerebral blood flow after acetazolamide: an experimental study comparing near-infrared spectroscopy and SPECT. Eur J Neurol. 2009;16:461–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Mahan GD, Engler WE, Tiemann JJ, Uzgiris E. Ultrasonic tagging of light: theory. Proc Natl Acad Sci USA. 1998;95:14015–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Sveinsdottir E, Torlof P, Risberg J, Ingvar DH, Lassen NA. Monitoring regional cerebral blood flow in normal man with a computer-controlled 32-dector system. Eur Neurol. 1971;6:228–33.PubMedCrossRefGoogle Scholar
  15. 15.
    Settakis G, Molnar C, Kerenyi L, Kollar J, Legemate D, Csiba L, Fulesdi B. Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature. Eur J Neurol. 2003;10:609–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Yao G, Wang LV. Theoretical and experimental studies of ultrasound-modulated optical tomography in biological tissue. Appl Opt. 2000;39:659–64.PubMedCrossRefGoogle Scholar
  17. 17.
    Racheli N, Ron A, Metzger Y, Breskin I, Enden G, Balberg M, Shechter R. Non-invasive blood flow measurements using ultrasound modulated diffused light. In: Oravesky AA, Wang LV, editors. SPIE Conference Proceedings 8223 (Photons Plus Ultrasound: Imaging and Sensing). 2012.Google Scholar
  18. 18.
    Ron A, Racheli N, Breskin I, Metzger Y, Silman Y, Kamar M, Nini A, Shechter R, Balberg M. Measuring tissue blood flow using ultrasound modulated diffused light. In: Oravesky AA, Wang LV, editors. SPIE Conference Proceedings 8223 (Photons Plus Ultrasound: Imaging and Sensing). 2012.Google Scholar
  19. 19.
    Celsis P, Goldman T, Henriksen L, Lassen NA. A method for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr. 1981;5:641–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561–77.PubMedGoogle Scholar
  21. 21.
    Pocock S. A practical approach. London: Wiley; 1983. p. 123–41.Google Scholar
  22. 22.
    Jobsis FF. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science. 1977;198:1264–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Murkin JM, Arango M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth. 2009;103(Suppl 1):i3–13.PubMedCrossRefGoogle Scholar
  24. 24.
    Rostrup E, Law I, Pott F, Ide K, Knudsen GM. Cerebral hemodynamics measured with simultaneous PET and near-infrared spectroscopy in humans. Brain Res. 2002;954:183–93.PubMedCrossRefGoogle Scholar
  25. 25.
    Rasmussen P, Dawson EA, Nybo L, van Lieshout JJ, Secher NH, Gjedde A. Capillary-oxygenation-level-dependent near-infrared spectrometry in frontal lobe of humans. J Cereb Blood Flow Metab. 2007;27:1082–93.PubMedGoogle Scholar
  26. 26.
    Rootwelt K, Dybevold S, Nyberg-Hansen R, Russell D. Measurement of cerebral blood flow with 133Xe inhalation and dynamic single photon emission computer tomography. Normal values. Scand J Clin Lab Invest Suppl. 1986;184:97–105.PubMedGoogle Scholar
  27. 27.
    Lassen LH. The effect of i.v. L-NG methylarginine hydrochloride (L-NMMA: 546C88) on basal and acetazolamide (Diamox) induced changes of blood velocity in cerebral arteries and regional cerebral blood flow in man. Cephalalgia. 2004;25:344–52.CrossRefGoogle Scholar
  28. 28.
    Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest. 1984;74:1634–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Bruhn H, Kleinschmidt A, Boecker H, Merboldt KD, Hanicke W, Frahm J. The effect of acetazolamide on regional cerebral blood oxygenation at rest and under stimulation as assessed by MRI. J Cereb Blood Flow Metab. 1994;14:742–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Demolis P, Chalon S, Giudicelli JF. Acetazolamide-induced vasodilation in the carotid vascular bed in healthy volunteers. J Cardiovasc Pharmacol. 1995;26:841–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Bickler PE, Litt L, Banville DL, Severinghaus JW. Effects of acetazolamide on cerebral acid-base balance. J Appl Physiol. 1988;65:422–7.PubMedGoogle Scholar
  32. 32.
    Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev. 1959;39:183–238.PubMedGoogle Scholar
  33. 33.
    Christensen MS, Hoedt-Rasmussen K, Lassen NA. The cerebral blood flow during halothane anaesthesia. Acta Neurol Scand Suppl. 1965;14:152–5.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Henrik W. Schytz
    • 1
  • Song Guo
    • 1
  • Lars T. Jensen
    • 2
  • Moshe Kamar
    • 3
  • Asaph Nini
    • 3
  • Daryl R. Gress
    • 4
  • Messoud Ashina
    • 1
    Email author
  1. 1.Danish Headache Center and Department of Neurology, Glostrup Hospital, Faculty of Health SciencesUniversity of CopenhagenGlostrupDenmark
  2. 2.Clinical Physiology and Nuclear Medicine, Glostrup Hospital, Faculty of Health SciencesUniversity of CopenhagenGlostrupDenmark
  3. 3.Ornim Medical Ltd.LodIsrael
  4. 4.Department of Neurology and NeurosurgeryUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations